Skip to content

How well is the efficacy of hepatitis A vaccination in elderly people?

How well is the efficacy of hepatitis A vaccination in elderly people? - Hepatitis A vaccination in elderly

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34411
Enrollment
60
Registered
2010-09-03
Start date
2010-10-27
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatitis A vaccination jaundice

Interventions

None listed

Sponsors

Alysis Zorggroep
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. elderly >60 years, or

Exclusion criteria

Exclusion criteria: 1. people

Design outcomes

Primary

MeasureTime frame
The time that is needed to achieve a protective antibody level against hepatitis A.

Secondary

MeasureTime frame
The height of antibody level against hepatitis A.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)